⌘K

21:36:05·70d

SECFilingvia Quantisnow

Amendment: SEC Form SCHEDULE 13G/A filed by Treace Medical Concepts Inc.

ByQuantisnow·Wall Street's wire, on your screen.

TMCI· Treace Medical Concepts Inc.

Health Care

Original source

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Companies

TMCI
Treace Medical Concepts Inc.
Health Care

Recent analyst ratings

Nov 7UpdateAnalyst$5.00
Nov 7UpdateBTIG Research-
Feb 4UpdateBTIG Research$16.00
Dec 31UpdateLake Street$14.50
Dec 17UpdateAnalyst$8.00
May 16UpdateUBS$6.50

Related

PR4d
Treace to Report First Quarter 2026 Financial Results on May 8, 2026
INSIDER8d
SEC Form 4 filed by Hair Mark
SEC19d
Treace Medical Concepts Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Leadership Update
PR21d
Treace Announces First Surgical Cases with the SuperBite™ Compression Screw System
SEC22d
SEC Form DEF 14A filed by Treace Medical Concepts Inc.
SEC22d
SEC Form DEFA14A filed by Treace Medical Concepts Inc.
INSIDER25d
SEC Form 4 filed by Hair Mark
INSIDER48d
Chief Executive Officer Treace John T. covered exercise/tax liability with 7,083 shares, decreasing direct ownership by 0.10% to 7,004,550 units (SEC Form 4)